Zhibao’s BTC-for-Equity PIPE: A Leveraged Bet on the Wrong Ledger

CryptoNode
Security

The market saw a 1.547 billion dollar PIPE and a 2,380 BTC balance sheet. I saw a 4.42 billion unit dilution event with a 0.35 dollar strike price that will bleed into the secondary market for years.

On August 19, 2024, Zhibao Technology (ZBAO), a Shanghai-based insurtech firm listed on the Nasdaq, announced it had completed a private placement of 442 million PIPE units. Each unit consisted of one Class A ordinary share and one warrant—exercisable at 0.35 dollars for two years. The catch: investors paid for these units not with cash, but with 2,380 Bitcoin. The company locked the BTC into its treasury as a “long-term reserve asset” and will use the proceeds for operations, R&D, and AI applications tied to insurance.

This is not MicroStrategy’s playbook. MicroStrategy buys BTC with cash. ZBAO skipped the cash step entirely—issuing equity directly in exchange for the asset. At a fixed reference price of $65,000 per BTC, the deal valued the PIPE at roughly $154.7 million. But the true cost is measured in future dilution, not in dollars.

Let me audit the mechanics. The 442 million units represent approximately 89.5% of the total PIPE, with the remaining 46.3 million units to be delivered upon shareholder approval of an increased authorized share count—at no additional cost. Every unit carries a warrant that, if exercised, adds another layer of dilution. The price per unit is $0.35. Without knowing ZBAO’s pre-issue market cap, I can’t calculate the exact discount, but given that the company’s market cap is likely below $100 million (insurtech, small cap, China ADR), the dilution is massive. The new shares alone could double or triple the float.

I have seen this pattern before. In 2020, during my Uniswap V2 migration, I learned that concentrated liquidity positions decay faster than you expect. The PIPE structure here is a concentrated bet on BTC appreciation, but the decay is shareholder equity. The 2,380 BTC represent a 100% allocation of the financing proceeds to a single volatile asset. There is no cash buffer. If BTC drops 30%, the treasury loses $46 million, and the stock will trade at a discount to book value.

When the code bleeds, only the ledger survives. The ledger here is the BTC blockchain. The company has not disclosed its custody arrangement. “Company-designated wallet” is a red flag. In 2017, I audited a Symbiont smart contract that had a reentrancy vulnerability in its equity transfer function. The code looked clean, but the state transitions were wrong. I spent six weeks tracing the logic. ZBAO’s custody is a black box. No third-party audit, no multi-sig details, no insurance. The private key is a single point of failure. If the company self-custodies, one misplaced key and the 2,380 BTC are gone. The market will not discover this until it is too late.

I do not trust whispers; I trust verified hashes. The transaction hash for the 2,380 BTC transfer is public, but the accounting treatment is not. The company issued shares at a fixed BTC price of $65,000. If the actual price on August 19 was $58,000, the investors effectively received a 12% discount on the equity. The SEC will likely issue a comment letter on the fair value measurement of non-cash consideration. I have seen this play out in 2022 when Celsius failed. The accounting loopholes were the first cracks. ZBAO’s 6-K filing is a starting point, but the real risk is in the footnotes.

The contrarian angle: most analysts will compare ZBAO to MicroStrategy and call it a “mini-MSTR” narrative play. That is lazy. MicroStrategy has a massive BTC holdings, a strong brand, and institutional-grade custody. ZBAO is a sub-$100 million market cap insurtech firm with a Chinese domicile. The regulatory risk is two-tier: the SEC requires full disclosure, but China bans crypto for its citizens. The company operates in Shanghai, holds BTC on its balance sheet, and issues shares to US investors. This is a jurisdictional straddle that will eventually break. The remaining 46.3 million units are contingent on shareholder approval. If the vote fails, the investors get no additional shares, but they already have 395 million units. The approval is a binary event. If it passes, dilution accelerates. If it fails, the PIPE investors may sue for breach of contract. Either way, the stock is trapped.

Chaos is just data waiting for a ledger. The data here is clear: the PIPE is a leveraged bet on BTC with a ticking dilution clock. The company’s core business—insurance technology—generates revenue, but the BTC reserve adds no operational synergy. The AI + insurance + BTC narrative is a marketing overlay, not a product. The only way this works is if BTC price doubles and the company sells later to cover the dilution. But the stated intent is “long-term reserve,” so they won’t sell. The stock becomes a proxy for BTC with a 0.35 dollar strike price embedded in the warrants. Every time the stock trades above 0.35, the warrants become in-the-money, and more dilution looms.

Takeaway: ZBAO is a levered bet on BTC with a ticking dilution clock. The PIPE investors got a discount, the company got a volatile asset, and the retail crowd gets the volatility. Watch the shareholder vote date. Watch the BTC price. If BTC drops below $50,000, the 2,380 BTC will be underwater, and the stock will follow. The gas war taught me that speed is a tax—but in this case, speed is the dilution that compounds before you can exit. The only safe position is on the sidelines, verifying the hashes.